Director may require additional information, under 37 CFR 1.137, re the federal patent office procedures. The transparency originates of MECINCORP, in the matter of the patent reinstatement.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.